In contrast, impaired in vitro generation of CD8+ Tregs was observed in 1/3 of SSc patients since in vitro-generated CD8+ Tregs from 10 out of 28 SSc patients failed to exert a suppressive activity above the 25% threshold. This evidence concerns the gene CD8A and systemic sclerosis.